9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis

NCT04510220 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Ofatumumab
DRUG: [F-18]PBR06

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]